Written Question·Department of Health and Social Care·UIN 120765
Blood Cancer: Immunotherapy
Tabled: 16 March 2026
Answered: 19 March 2026
Named DayQuestion
Mr Clive Betts
Labour — Sheffield South East
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that access to CAR-T therapies for mantle cell lymphoma is consistent across the UK, in the context of its continued availability in Scotland.
Answer
Dr Zubir AhmedThe National Institute for Health and Care Excellence (NICE) is re-evaluating brexucabtagene autoleucel following managed access through the Cancer Drugs Fund to determine whether it should be recommended for routine National Health Service funding. NICE’...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 120765) →